Bringing together over 150 industry and academic experts working in areas such as molecular biology/diagnostics, gene expression, genomics, biomarkers, pathogen detection, and miRNA analysis, the congress will examine the latest developments, opportunities and applications of both dPCR and qPCR through case studies across diverse areas such as oncology, infectious diseases, vaccines, clinical applications, microbiology, and other novel applications.
With increasing numbers of real-time PCR users purchasing digital PCR due to the reduction in its cost, absolute quantification, improved sensitivity, precision and greater robustness; and with the qPCR and Digital PCR market predicted to grow to $4.94 billion by 2021, this conference provides a timely opportunity to learn first-hand about dPCR whilst also keeping up to date with latest developments and strategies in qPCR.
The conference will provide an interactive networking forum to both further develop and answer your queries through a vibrant exhibition room full of technology providers showcasing their technologies and other solutions, poster presentation sessions, and expert led case study presentations from a 30-strong speaker faculty examining topics on 3 separate tracks covering:
– Digital PCR: Possibilities & Opportunities
– qPCR: Strategies & Developments
– Healthcare Case Studies